HiberCell
1 follower
Despite significant advances in treatment of primary tumors, metastatic cancer remains a leading cause of solid cancer mortality. HiberCell seeks to change that. As “the dormancy company,” they are the first company exclusively focused on therapeutically modulating the biology and mechanisms of tumo... Read more
Org chart
Jonathan Lanfear
President & CEO
Jonathan Lanfear
Collapse
Ari Nowacek
Co-Founder & Chief Business Officer
José Iglesias
Consultant Chief Medical Officer
Nandita Bose
VP of Translational Immunology
Jehan Rowlands
VP of Regulatory Affairs
Crissy Dudgeon
Associate Director, InVitro Translational Oncology
Beth Johnson
Executive Assistant & Officer Manager
Cindy Jacobs Ph.D., M.D.
Independent Board Director
Eric Lightcap
Vice President
Jeremy Drees
Director, Translational Medicine
Julio Aguirre-Ghiso
Scientific Founder, SAB member
Kyle Michel
Manager, Quality
Michael Danielson
Executive Director Head Of CMC
Paulette Mattson
Senior Manager, Clinical Trials
